These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25186790)

  • 21. Ceftriaxone versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia.
    Mohamed A; Bennett N; Ploetz J; Aragon L; Kennedy K; Boyd S
    Int J Antimicrob Agents; 2022 Sep; 60(3):106632. PubMed ID: 35787919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study.
    Wang JT; Hsu LY; Lauderdale TL; Fan WC; Wang FD
    PLoS One; 2015; 10(12):e0144710. PubMed ID: 26690351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
    Parta M; Goebel M; Thomas J; Matloobi M; Stager C; Musher DM
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1043-8. PubMed ID: 20731594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    Twilla JD; Algrim A; Adams EH; Samarin M; Cummings C; Finch CK
    Am J Med Sci; 2020 Jul; 360(1):35-41. PubMed ID: 32376001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
    Blumenthal KG; Shenoy ES; Huang M; Kuhlen JL; Ware WA; Parker RA; Walensky RP
    PLoS One; 2016; 11(7):e0159406. PubMed ID: 27438379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.
    Monogue ML; Ortwine JK; Wei W; Eljaaly K; Bhavan KP
    J Infect Public Health; 2018; 11(5):727-731. PubMed ID: 29526442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus.
    Li J; Echevarria KL; Hughes DW; Cadena JA; Bowling JE; Lewis JS
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5117-24. PubMed ID: 24936596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Gern BH; Greninger AL; Weissman SJ; Stapp JR; Tao Y; Qin X
    Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):5. PubMed ID: 29463249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants.
    Shane AL; Hansen NI; Stoll BJ; Bell EF; Sánchez PJ; Shankaran S; Laptook AR; Das A; Walsh MC; Hale EC; Newman NS; Schrag SJ; Higgins RD;
    Pediatrics; 2012 Apr; 129(4):e914-22. PubMed ID: 22412036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
    McDanel JS; Roghmann MC; Perencevich EN; Ohl ME; Goto M; Livorsi DJ; Jones M; Albertson JP; Nair R; O'Shea AMJ; Schweizer ML
    Clin Infect Dis; 2017 Jul; 65(1):100-106. PubMed ID: 28379314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
    Davis JS; Turnidge J; Tong S
    Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftriaxone for the Treatment of Methicillin-susceptible
    Lowe RA; Barber KE; Wagner JL; Bell-Harlan AM; Stover KR
    J Pharmacol Pharmacother; 2017; 8(3):140-144. PubMed ID: 29081626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study.
    Rubio-Terrés C; Garau J; Grau S; Martinez-Martinez L;
    Clin Microbiol Infect; 2010 Jun; 16(6):722-8. PubMed ID: 19712112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable
    Jones D; Elshaboury RH; Munson E; Dilworth TJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038267
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
    Kim SH; Kim KH; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2008 Jan; 52(1):192-7. PubMed ID: 17984229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.
    Lee BJ; Rao SN; Wang SK; Lee JY; Lakada IY; Gilbert EM; Barr VO; Postelnick MJ; Sutton SH; Zembower TR; Bolon M; Scheetz MH; Rhodes NJ
    Int J Antimicrob Agents; 2017 May; 49(5):650-654. PubMed ID: 28279787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremia.
    Obed MN; Toresani I; Mykietuk A; Nannini EC
    Medicina (B Aires); 2022; 82(5):794-797. PubMed ID: 36220043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and outcomes of community-onset methicillin-susceptible Staphylococcus aureus bacteraemia in a university hospital in Singapore.
    Chia JW; Hsu LY; Chai LY; Tambyah PA
    BMC Infect Dis; 2008 Feb; 8():14. PubMed ID: 18254979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan.
    Tsuzuki S; Yu J; Matsunaga N; Ohmagari N
    Public Health; 2021 Sep; 198():292-296. PubMed ID: 34507134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.